GHO Capital Managing Partner Mike Mortimer, and Sam Ulin, Partner at ClearView Healthcare Partners recently shared insights in BioCentury: ‘Pharma's commercial revolution: How integrated DTC models elevate and empower patients’
The pharmaceutical industry is experiencing a major shift toward integrated direct-to-consumer (DTC) models bypassing intermediaries by combining patient engagement, prescribing, and drug fulfilment into unified digital platforms. Initially proven in obesity treatments during drug shortages, these models streamline access and reduce therapy initiation from weeks to days, while giving patients greater autonomy and transparency. Despite regulatory challenges, major pharmaceutical companies are expanding these platforms across multiple therapeutic areas, signalling a transformation toward patient-centric care that empowers individuals and enables innovation, focused directly on patient needs rather than payer priorities.
Read the full article here: https://www.biocentury.com/article/657605
